Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
Contrary to initial expectations, angiogenesis inhibitors can cause toxicities in patients with cancer. The toxicity profiles of these inhibitors reflect the disturbance of growth factor signalling pathways that are important for maintaining homeostasis. Experiences with angiogenesis inhibitors in c...
Saved in:
Published in | Nature reviews. Cancer Vol. 7; no. 6; pp. 475 - 485 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
01.06.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Contrary to initial expectations, angiogenesis inhibitors can cause toxicities in patients with cancer. The toxicity profiles of these inhibitors reflect the disturbance of growth factor signalling pathways that are important for maintaining homeostasis. Experiences with angiogenesis inhibitors in clinical trials indicate that short-term toxicities are mostly manageable. However, these agents will also be given in prolonged treatment strategies, so we need to anticipate possible long-term toxicities. In addition, understanding the molecular mechanisms involved in the toxicity of angiogenesis inhibition should allow more specific and more potent inhibitors to be developed. |
---|---|
ISSN: | 1474-175X 1474-1768 |
DOI: | 10.1038/nrc2152 |